Search filters

List of works by Evgenii A Osmanov

Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study

scientific article published on 05 June 2017

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial ⬇️

scientific article published on July 1, 2011

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma

scientific article

Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

scientific article

Prespecified candidate biomarkers identify follicular lymphoma patients who achieved longer progression-free survival with bortezomib-rituximab versus rituximab.

scientific article published on 02 April 2013

Paulina is supported by:

About Paulina

Help